Literature DB >> 16449222

Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides.

Piotr Lewczuk, Georg Beck, Hermann Esselmann, Ralf Bruckmoser, Rüdiger Zimmermann, Magdalena Fiszer, Mirko Bibl, Juan Manuel Maler, Johannes Kornhuber, Jens Wiltfang.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16449222     DOI: 10.1373/clinchem.2005.058776

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  51 in total

1.  The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease.

Authors:  Sebastiaan Engelborghs; Nathalie Le Bastard
Journal:  Mol Diagn Ther       Date:  2012-06-01       Impact factor: 4.074

2.  Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices.

Authors:  Mauro Fa; Ian J Orozco; Yitshak I Francis; Faisal Saeed; Yimin Gong; Ottavio Arancio
Journal:  J Vis Exp       Date:  2010-07-14       Impact factor: 1.355

3.  Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.

Authors:  Sonia M Vallabh; Chloe K Nobuhara; Franc Llorens; Inga Zerr; Piero Parchi; Sabina Capellari; Eric Kuhn; Jacob Klickstein; Jiri G Safar; Flavia C Nery; Kathryn J Swoboda; Michael D Geschwind; Henrik Zetterberg; Steven E Arnold; Eric Vallabh Minikel; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

Review 4.  Biobanking of Cerebrospinal Fluid.

Authors:  Randy S Tashjian; Harry V Vinters; William H Yong
Journal:  Methods Mol Biol       Date:  2019

5.  Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Michal Figurski; Els Coart; Kaj Blennow; Holly Soares; Adam J Simon; Piotr Lewczuk; Robert A Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-02-11       Impact factor: 17.088

6.  Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

Authors:  Volker Welge; Oliver Fiege; Piotr Lewczuk; Brit Mollenhauer; Hermann Esselmann; Hans-Wolfgang Klafki; Stefanie Wolf; Claudia Trenkwalder; Markus Otto; Johannes Kornhuber; Jens Wiltfang; Mirko Bibl
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

Review 7.  Neurochemical dementia diagnostics: assays in CSF and blood.

Authors:  Piotr Lewczuk; Joachim Hornegger; Rüdiger Zimmermann; Markus Otto; Jens Wiltfang; Johannes Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

8.  Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

Authors:  Maria Bjerke; Erik Portelius; Lennart Minthon; Anders Wallin; Henrik Anckarsäter; Rolf Anckarsäter; Niels Andreasen; Henrik Zetterberg; Ulf Andreasson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-15

9.  Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.

Authors:  Niklas Mattsson; Henrik Zetterberg; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-08

10.  Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.

Authors:  Mirko Bibl; Hermann Esselmann; Piotr Lewczuk; Claudia Trenkwalder; Markus Otto; Johannes Kornhuber; Jens Wiltfang; Brit Mollenhauer
Journal:  Int J Alzheimers Dis       Date:  2010-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.